度他雄胺
Dutasteride;(5alpha,17beta)-n-{2,5-bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide;(4aR,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide;(4aR,6aS,7S)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide;Avodart;Duagen;GG 745;GI198745;Avolve;(5α,17β)-;Dutasteride API;GG-745, GI-198745,;Dutasteride (200 mg);Dutasteride(Avodart);GI 198745;O0J6XJN02I;Dutasteride, 99%;Avidart;(4ar,4bs,6as,7s,9as,9bs,11ar)-n-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1h-indeno[5,4-f]quinoline-7-carboxamide;JALYN COMPONENT DUTASTERIDE;BCP02344;EX-A1952;alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide;DUTASTERIDE [WHO-DD];DUTASTERIDE (USP-RS);Dutasteride (JAN/USP/INN);(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide;1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-;NCGC00164571-01;UNII-O0J6XJN02I;BD164398;Dutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard;GS-3565;Dutasteride, >=98% (HPLC);Z1558504346;DUTASTERIDE (MART.);CHEMBL1200969;164656-23-9;DUTASTERIDE [MART.];BCPP000248;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamide;DTXSID8046452;CS-1542;Dutasteride, European Pharmacopoeia (EP) Reference Standard;NSC 759880;Q-201052;CHEBI:521033;DUTASTERIDE [USP-RS];AKOS015920136;D5973;NSC 740477;(1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide;A810580;D03820;Dutasteride- Bio-X;(1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide;GG-745;AKOS015924431;AB01274774-01;DUTASTERIDE [USP MONOGRAPH];NSC740477;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(2,5-Bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide;DTXCID6026452;BDBM50340481;AB01274774_02;Dutasteride, United States Pharmacopeia (USP) Reference Standard;Tox21_112199;DUTASTERIDE [INN];G04CB02;Q424760;BRD-K30373883-001-02-8;(5alpha,17beta)-N-[2,5-Bis(trifluoromethyl)phenyl]...